Abadi SSH,Gangadharappa H,Balamuralidhara VJ. .2020 .Development of colon-specific mucoadhesive meloxicam microspheres for the treatment of CFA induced arthritis in rats. Int. J. Polyme. Mate. Polyme. Biomater, 70(12) : 849-869.
Alvi Z,Akhtar M,Rahman NU,Hosny KM,Sindi AM,Khan BA,Nazir I,Sadaquat H I .2021 .Utilization of gelling polymer to formulate nanoparticles loaded with epalrestat-cyclodextrin inclusion complex: Formulation, characterization, in-silico modelling and in-vivo toxicity Evaluation. , 13(24) : 4350.
Anwar S,Jan SU,Gul R .2020 .Formulation and evaluation of celecoxib cream and its released study. Int. J. Curr. Pharm. Res., (5): 10.22159, : .
Bae JW,Kim MJ,Jang CG,Lee SY .2007 .Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J. Chromatograp. B., 859(1) : 69-73.
Chawla G,Gupta P,Thilagavathi R,Chakraborti AK,Bansal AK .2003 .Characterization of solid-state forms of celecoxib. Eur. J. Pharm. Sci., 20(3) : 305-317.
Chowdary KPR,Sekuboyina VS .2006 .Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl β-cyclodextrin. AAPS Pharm. Sci. Tech, 7(3) : E184-89.
Chaudhari VS,Borkar RM,Murty US,Banerjee S US .2020 .Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. J. Pharmaceu. Biomed. Analy., 186 : 113325.
Ford J .1999 .Thermal Analysis of Hydroxypropylmethylcellulose and Methylcellulose: Powders, gels and matrix tablets. Int. J. Pharmaceu., 179(2) : 209-228.
Eun-Sol Ha,Hee-Young Jeong,Gwang-Ho Choo,Young-Suk Jung,Jeong-Soo Kim,Sung-Joo Hwang Kim,Min-Soo Kim Kim .2015 .Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant. Int. J. Biolo. Macromole., 72 : 1473-1478.
Gul R,Jan SU,Ahmad M,Akhtar M,Qureshi MM .2019 .Formulation, characterization and in vivo evaluation of hedera helix l., topical dosage forms. Pak. J. Pharm. Sci., 32(6) : 2605-2610.
Hamid HA,Khan S,Noor Shah SM,Asghar M,Shahid M,Hussain Z,Sohail M,Khan BA,Amin F,Jan SU,Elhissi A,Shah SMH,Minhas MU,Shah SWA,Ahmad N SWA .2021 .Piroxicam loaded polymer hybrid microspheresbased tablets with modified release kinetics: Development, characterization and in vivo evaluation. Pak. J. Pharm. Sci., 34(1 Supplementary)) : 327-335.
Hnatyszyn A,Hryhorowicz S,Kaczmarek-Ryś M,Lis E,Słomski R,Scott RJ,Pławski A .2019 .Colorectal carcinoma in the course of inflammatory bowel diseases. Hered. Cancer Clin. Pract, 17(1) : 1-9.
Kashif PM,Madni A,Ashfaq M,Rehman M,Mahmood MA,Khan MI,Tahir N MI .2017 .Development of Eudragit RS 100 microparticles loaded with ropinirole: Optimization and in vitro evaluation Studies. AAPS Pharm. Sci. Tech, 18(5) : 1810-1822.
Katona G,Balogh GT,Dargo G,Gáspár R,Márki Á,Ducza E,Sztojkov-Ivanov A,Tomosi F,Kecskeméti G,Janáky T .2020 .Development of meloxicam human serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach. J. Pharmaceutics, 12(2) : 97.
Krier F,Brion M,Debrus B,Lebrun P,Driesen A,Ziemons E,Evrard B,Hubert P .2011 .Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J. Pharmaceut. Biomed. Analy., 54(4) : 694-700.
Lu GW,Hawley M,Smith M,Geiger BM,Pfund W .2006 .Characterization of a novel polymorphic form of celecoxib. J. Pharma. Sci., 95(2) : 305-317.
Maqbool I,Akhtar M,Ahmad R,Sadaquat H,Noreen S,Batool A,Khan SU .2020 .Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design. Eur. J. Pharm. Sci., 15 : 105254.
Nasr AM,Elhady SS,Swidan SA,Badawi NM .2020 .Celecoxib loaded in-situ provesicular powder and its invitro cytotoxic effect for cancer therapy: Fabrication, characterization, optimization and pharmacokinetic evaluation. Pharmaceu, 12(12) : 1157.
Wasay SA,Jan SU,Akhtar M,Noreen S,Gul R .2022 .Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization and in-vivo toxicity study. PLoS One, 17(4) : e0267306.
Patel MM .2017 .Formulation and development of didependent microparticulate system for colon-specific drug delivery. Drug deliv. and trans. res., 7(2) : 312-324.
Q8 I .2005 .ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q9: Quality Risk Management Geneva. , : .
Rowe RC,Sheskey PJ,Owen SC .2006 .Handbook of Pharmaceutical Excipients. , : 278-560.
Salunkhe NH,Jadhav NR,Bhinge SD .2018 .Validated RP-HPLC method for quantification of felodipine in rabbit plasma: Application in a bioequivalence study. , 77(1) : 15-19.
Sharma M,Kohli S,Dinda A .2015 .In-vitro and in vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. , 23(6) : 675-682.
Vijayakumar B,Kannappan V,Sathyanarayana V,Mole V .2016 .DFT analysis and spectral characteristics of Celecoxib a potent COX-2 inhibitor. , 1121 : 16-25.
Wasay SA,Jan SU,Akhtar M,Rabbiya A,Shah PA,Razaque G,Muhammad S,Shahwani NA,Younis M,Achakzai JK .2022 .Meloxicam loaded hydroxypropyl methylcellulose (HPMC) microparticulate: Fabrication, characterization and in vivo pharmacokinetic assessment. Pak. J. Pharm. Sci., 35 : 1251-1260.
Xi Y,Xu P Y .2021 .Global colorectal cancer burden in 2020 and projections to 2040. , 14(10) : 101174.
Ziaei E,Emami J,Kazemi M,Rezazadeh M M .2020 .Simultaneous determination of docetaxel and celecoxib in porous microparticles and rat plasma by liquid-liquid extraction and HPLC with UV detection: In vitro and in vivo validation and application. J. Pharm. Pharm. Sci., 23 : 289-303.